135 related articles for article (PubMed ID: 31261446)
1. A validated high-performance liquid chromatography-tandem mass spectrometry method for quantification of gefitinib and its main metabolites in xenograft mouse tumor: Application to a pharmacokinetics study.
Zhao C; Zheng N; Yang F; Han SY; Li PP
Biomed Chromatogr; 2019 Nov; 33(11):e4638. PubMed ID: 31261446
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of gefitinib and its major metabolites in mouse plasma by HPLC-MS/MS and its application to a pharmacokinetics study.
Zheng N; Zhao C; He XR; Jiang ST; Han SY; Xu GB; Li PP
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():215-22. PubMed ID: 26795401
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients.
Guan S; Chen X; Wang F; Xin S; Feng W; Zhu X; Liu S; Zhuang W; Zhou S; Huang M; Wang X; Zhang L
J Pharm Biomed Anal; 2019 Aug; 172():364-371. PubMed ID: 31096095
[TBL] [Abstract][Full Text] [Related]
4. Application of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to the pharmacokinetics, tissue distribution and excretion studies of felotaxel (SHR110008) in tumor-bearing mice.
Ding Y; Lu C; Yang J; Jin X; Yang L; Wang C; Ma Z; Zhu Y; Ding L; Jia Y; Wen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():61-6. PubMed ID: 22309773
[TBL] [Abstract][Full Text] [Related]
5. HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies.
Zangarini M; Ceriani L; Bello E; Damia G; Cereda R; Camboni MG; Zucchetti M
J Mass Spectrom; 2014 Jan; 49(1):19-26. PubMed ID: 24446259
[TBL] [Abstract][Full Text] [Related]
6. Marsdenia tenacissima extract promotes gefitinib accumulation in tumor tissues of lung cancer xenograft mice via inhibiting ABCG2 activity.
Zhao C; Hao H; Zhao H; Ren W; Jiao Y; An G; Sun H; Han S; Li P
J Ethnopharmacol; 2020 Jun; 255():112770. PubMed ID: 32205262
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a method for gefitinib quantification in dried blood spots using liquid chromatography-tandem mass spectrometry: Application to finger-prick clinical blood samples of patients with non-small cell lung cancer.
Irie K; Shobu S; Hiratsuji S; Yamasaki Y; Nanjo S; Kokan C; Hata A; Kaji R; Masago K; Fujita S; Okada Y; Katakami N; Fukushima S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1087-1088():1-5. PubMed ID: 29689441
[TBL] [Abstract][Full Text] [Related]
8. Determination of intracellular anlotinib, osimertinib, afatinib and gefitinib accumulations in human brain microvascular endothelial cells by liquid chromatography/tandem mass spectrometry.
Ma Z; Lu S; Zhou H; Zhang S; Wang Y; Lin N
Rapid Commun Mass Spectrom; 2021 Jan; 35(1):e8955. PubMed ID: 32990383
[TBL] [Abstract][Full Text] [Related]
9. The Quantification of Paclitaxel and Its Two Major Metabolites in Biological Samples by HPLC-MS/MS and Its Application in a Pharmacokinetic and Tumor Distribution Study in Xenograft Nude Mouse.
Huang H; Huang H; Sun Y; Liu Q
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770692
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice.
Jin X; Zhou F; Liu Y; Cheng C; Yao L; Jia Y; Wang G; Zhang J
J Pharm Biomed Anal; 2018 Sep; 158():1-7. PubMed ID: 29843006
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitative estimation of new imiqualine leads with potent anticancer activities in rat and mouse plasma. Application to a pharmacokinetic study in mice.
Chouchou A; Marion B; Enjalbal C; Roques C; Cuq P; Bonnet PA; Bressolle-Gomeni FMM; Deleuze-Masquéfa C
J Pharm Biomed Anal; 2018 Jan; 148():369-379. PubMed ID: 29111492
[TBL] [Abstract][Full Text] [Related]
12. Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometry.
Wang LZ; Lim MY; Chin TM; Thuya WL; Nye PL; Wong A; Chan SY; Goh BC; Ho PC
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2155-61. PubMed ID: 21703945
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an HPLC-MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run.
van Veelen A; van Geel R; Schoufs R; de Beer Y; Stolk LM; Hendriks LEL; Croes S
Biomed Chromatogr; 2021 Dec; 35(12):e5224. PubMed ID: 34363425
[TBL] [Abstract][Full Text] [Related]
14. Development of a simple and rapid HPLC-MS/MS method for quantification of streptomycin in mice and its application to plasma pharmacokinetic studies.
Wang Z; Xie C; Yeung S; Wang J; Chow MSS
Biomed Chromatogr; 2019 Feb; 33(2):e4408. PubMed ID: 30324683
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an UPLC-MS/MS method for simultaneous determination of fifteen targeted anti-cancer drugs in human plasma and its application in therapeutic drug monitoring.
Li G; Zhao M; Zhao L
J Pharm Biomed Anal; 2022 Apr; 212():114517. PubMed ID: 35131665
[TBL] [Abstract][Full Text] [Related]
16. An HPLC-MS/MS method for simultaneous determination of the active metabolites of febuxostat (67M-1, 67M-2 and 67M-4) in human plasma.
Xie H; Wang Z; Deng K; Jiang X; Wang L; Lv G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 970():24-30. PubMed ID: 25222745
[TBL] [Abstract][Full Text] [Related]
17. A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection.
Zhuang Q; Liu X; Sun Z; Wang H; Jiang J
J Pharm Biomed Anal; 2019 Jun; 170():112-123. PubMed ID: 30921645
[TBL] [Abstract][Full Text] [Related]
18. Determination and pharmacokinetics study of oxyclozanide suspension in cattle by LC-MS/MS.
Zhang J; Bai Y; Li B; Zhou X; Si H; Zhang J
BMC Vet Res; 2019 Jun; 15(1):210. PubMed ID: 31234851
[TBL] [Abstract][Full Text] [Related]
19. Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor.
McKillop D; Partridge EA; Kemp JV; Spence MP; Kendrew J; Barnett S; Wood PG; Giles PB; Patterson AB; Bichat F; Guilbaud N; Stephens TC
Mol Cancer Ther; 2005 Apr; 4(4):641-9. PubMed ID: 15827338
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous online SPE-HPLC-MS/MS quantification of gefitinib, osimertinib and icotinib in dried plasma spots: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Jia M; Wu Z; Shi W; Wang S; Huang X; Zhang M; Bao W; Bao A; Zhang P; Ding F; Xie G; Lou Y; Fan G
J Pharm Biomed Anal; 2023 May; 228():115275. PubMed ID: 36871365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
